Article
The effect of interleukin-21 on HBV-related hepatocellular carcinoma, from the perspective of genetics.
World journal of surgical oncology - 16 Apr 2026
Wang Xi, Yao Yanping, Chen Xu, Qiu Jun, Fu Hailong
Abstract excerpt
BACKGROUND: Hepatocellular carcinoma (HCC) represents a major global health burden, with chronic hepatitis B virus (HBV) infection being its predominant cause. However, only a fraction of chronic HBV carriers progress to HCC, suggesting a critical role for host genetic susceptibility. Interleukin-21 (IL-21) is a key immunomodulatory cytokine implicated in anti-tumor immunity, yet the association between IL-21...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
